Medifast, Inc. (MED)
NYSE: MED · IEX Real-Time Price · USD
33.50
-0.07 (-0.21%)
Apr 25, 2024, 4:00 PM EDT - Market closed
Medifast Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Year | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 - 1995 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1,072 | 1,599 | 1,526 | 934.84 | 713.67 | 501 | 301.56 | 274.53 | 272.77 | 285.29 | Upgrade
|
| Revenue Growth (YoY) | -32.94% | 4.75% | 63.25% | 30.99% | 42.45% | 66.14% | 9.85% | 0.65% | -4.39% | -11.96% | Upgrade
|
| Cost of Revenue | 296.2 | 458.16 | 398.49 | 237.03 | 176.81 | 121.1 | 73.75 | 68.87 | 71.46 | 76.08 | Upgrade
|
| Gross Profit | 775.85 | 1,140 | 1,128 | 697.82 | 536.86 | 379.9 | 227.81 | 205.66 | 201.32 | 209.21 | Upgrade
|
| Selling, General & Admin | 649.45 | 955.61 | 911.36 | 563.66 | 445.82 | 310.84 | 188.18 | 178.81 | 172.63 | 178.96 | Upgrade
|
| Operating Expenses | 649.45 | 955.61 | 911.36 | 563.66 | 445.82 | 310.84 | 188.18 | 178.81 | 172.63 | 178.96 | Upgrade
|
| Operating Income | 126.4 | 184.81 | 216.24 | 134.16 | 91.04 | 69.06 | 39.63 | 26.86 | 28.68 | 30.25 | Upgrade
|
| Interest Expense / Income | -2.49 | 0.7 | 0.23 | -0.25 | -1.3 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Other Expense / Income | 0.1 | 0.05 | -0.12 | 0.14 | -0.03 | -1.49 | -0.69 | -0.26 | -1.48 | 6.4 | Upgrade
|
| Pretax Income | 128.8 | 184.06 | 216.13 | 134.27 | 92.36 | 70.55 | 40.33 | 27.12 | 30.16 | 23.85 | Upgrade
|
| Income Tax | 29.38 | 40.49 | 52.1 | 31.41 | 14.45 | 14.76 | 12.61 | 9.29 | 10.1 | 10.66 | Upgrade
|
| Net Income | 99.42 | 143.57 | 164.03 | 102.86 | 77.92 | 55.79 | 27.72 | 17.84 | 20.06 | 13.18 | Upgrade
|
| Net Income Growth | -30.75% | -12.48% | 59.47% | 32.01% | 39.66% | 101.25% | 55.43% | -11.08% | 52.17% | -45.01% | Upgrade
|
| Shares Outstanding (Basic) | 11 | 11 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 13 | Upgrade
|
| Shares Outstanding (Diluted) | 11 | 11 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 13 | Upgrade
|
| Shares Change | -3.15% | -4.55% | -0.31% | -2.20% | 0.31% | -0.07% | 1.18% | -1.03% | -5.53% | -7.52% | Upgrade
|
| EPS (Basic) | 9.13 | 12.82 | 14.01 | 8.74 | 6.62 | 4.67 | 2.32 | 1.51 | 1.68 | 1.04 | Upgrade
|
| EPS (Diluted) | 9.10 | 12.73 | 13.89 | 8.68 | 6.43 | 4.62 | 2.29 | 1.49 | 1.66 | 1.03 | Upgrade
|
| EPS Growth | -28.52% | -8.35% | 60.02% | 34.99% | 39.18% | 101.75% | 53.69% | -10.24% | 61.17% | -40.46% | Upgrade
|
| Free Cash Flow | 141.17 | 177.89 | 60.34 | 139.31 | 74.2 | 56.07 | 40.08 | 23.15 | 26.59 | 18.51 | Upgrade
|
| Free Cash Flow Per Share | 12.97 | 15.89 | 5.16 | 11.84 | 6.30 | 4.69 | 3.36 | 1.96 | 2.22 | 1.46 | Upgrade
|
| Dividend Per Share | 4.950 | 6.560 | 5.680 | 4.520 | 3.380 | 2.190 | 1.440 | 1.070 | 0.250 | - | Upgrade
|
| Dividend Growth | -24.54% | 15.49% | 25.66% | 33.73% | 54.34% | 52.08% | 34.58% | 328.00% | - | - | Upgrade
|
| Gross Margin | 72.37% | 71.34% | 73.89% | 74.65% | 75.22% | 75.83% | 75.54% | 74.91% | 73.80% | 73.33% | Upgrade
|
| Operating Margin | 11.79% | 11.56% | 14.17% | 14.35% | 12.76% | 13.78% | 13.14% | 9.78% | 10.52% | 10.60% | Upgrade
|
| Profit Margin | 9.27% | 8.98% | 10.75% | 11.00% | 10.92% | 11.14% | 9.19% | 6.50% | 7.35% | 4.62% | Upgrade
|
| Free Cash Flow Margin | 13.17% | 11.13% | 3.95% | 14.90% | 10.40% | 11.19% | 13.29% | 8.43% | 9.75% | 6.49% | Upgrade
|
| Effective Tax Rate | 22.81% | 22.00% | 24.11% | 23.39% | 15.64% | 20.92% | 31.26% | 34.24% | 33.50% | 44.72% | Upgrade
|
| EBITDA | 144.02 | 201.84 | 228.24 | 141.52 | 98.32 | 74.98 | 44.54 | 32.53 | 37.28 | 31.9 | Upgrade
|
| EBITDA Margin | 13.43% | 12.63% | 14.96% | 15.14% | 13.78% | 14.97% | 14.77% | 11.85% | 13.67% | 11.18% | Upgrade
|
| Depreciation & Amortization | 17.71 | 17.08 | 11.88 | 7.51 | 7.25 | 4.44 | 4.21 | 5.41 | 7.12 | 8.05 | Upgrade
|
| EBIT | 126.31 | 184.76 | 216.36 | 134.02 | 91.07 | 70.55 | 40.33 | 27.12 | 30.16 | 23.85 | Upgrade
|
| EBIT Margin | 11.78% | 11.56% | 14.18% | 14.34% | 12.76% | 14.08% | 13.37% | 9.88% | 11.06% | 8.36% | Upgrade
|